System and method for multiplexed affinity purification of proteins and cells

US10228313B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10228313-B2
Application numberUS-201515520176-A
CountryUS
Kind codeB2
Filing dateOct 23, 2015
Priority dateOct 24, 2014
Publication dateMar 12, 2019
Grant dateMar 12, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In accordance with an embodiment of the invention, there is provided a method for: a) high-throughput, multiplexed, affinity-based separation of proteins—especially low abundance proteins—from complex biological mixtures such as serum; and b) high-throughput, multiplexed, affinity-based separation of cells—especially rare cells—from complex biological mixtures such as blood or blood fractions. The separation of proteins or cells is achieved based on differential binding to affinity-capture beads of different sizes and then sorting the protein-bound or cell-bound beads using the concept of centrifugal-induced Dean migration in a spiral microfluidic device. This method enables continuous-flow, high throughput affinity-separation of milligram-scale protein samples or millions of cells in minutes after binding. This is particularly applicable to the isolation of antigen-specific antibodies from polyclonal sera and antigen-specific immune cells or circulating tumor cells from blood, both of which are otherwise highly labor-intensive and expensive to perform.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of separating at least one of a protein and a cell from a biological mixture, the method comprising: flowing a plurality of types of at least one of proteins and cells through at least one inlet of a spiral microfluidic device, each different type of the at least one of proteins and cells being bound to a corresponding different size of bead, the binding being based on an affinity between each such type of the at least one of proteins and cells and at least a portion of a surface of a bead to which each such type is bound; flowing the plurality of types of the at least one of proteins and cells, bound to the corresponding different sizes of beads, from the at least one inlet through a spiral channel of the spiral microfluidic device, thereby sorting, along a cross-section of the spiral channel, the plurality of types of the at least one of proteins and cells based on effective sizes of a plurality of combination particles, each combination particle comprising a type of the at least one of the protein and the cell bound to the corresponding different size of bead to which each type of the at least one of the protein and the cell is bound; and flowing the sorted types of the at least one of proteins and cells through a plurality of outlets of the spiral microfluidic device that are in fluid flow connection with the spiral channel, such that each outlet flows substantially only one type of the at least one of proteins and cells, bound to the corresponding different size of bead to which each such type is bound. 2. The method of claim 1 , wherein the at least one of the protein and the cell comprises an antigen-specific antibody. 3. The method of claim 1 , wherein the at least one of the protein and the cell comprises an antigen-specific cell. 4. The method of claim 1 , wherein the at least one of the protein and the cell comprises a circulating tumor cell. 5. The method of claim 1 , wherein the biological mixture comprises at least one blood component. 6. The method of claim 1 , wherein the biological mixture comprises whole blood. 7. The method of claim 1 , wherein the biological mixture comprises serum. 8. The method of claim 7 , wherein the biological mixture comprises a polyclonal serum. 9. The method of claim 1 , wherein each size bead of the corresponding different sizes of beads comprises a coated surface comprising a different type of at least one of an antigen or antibody that comprises an affinity with the corresponding at least one of the protein and the cell. 10. The method of claim 1 , wherein the plurality of types of at least one of proteins and cells comprises more than two types of at least one of proteins and cells. 11. The method of claim 1 , wherein the spiral channel has a length, and the cross-section has a height and a width defining an aspect ratio, such that the spiral channel is adapted, by virtue of the length and the cross-section, to sort, along a cross-section of the spiral channel, the plurality of types of the at least one of proteins and cells based on the effective sizes of the plurality of combination particles.

Assignees

Inventors

Classifications

  • G01N1/405Primary

    by adsorption or absorption · CPC title

  • specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules · CPC title

  • specially adapted for focusing or laminating flows · CPC title

  • Cards, e.g. flat sample carriers usually with flow in two horizontal directions · CPC title

  • fluid pressure, pneumatics · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10228313B2 cover?
In accordance with an embodiment of the invention, there is provided a method for: a) high-throughput, multiplexed, affinity-based separation of proteins—especially low abundance proteins—from complex biological mixtures such as serum; and b) high-throughput, multiplexed, affinity-based separation of cells—especially rare cells—from complex biological mixtures such as blood or blood fractions. …
Who is the assignee on this patent?
Massachusetts Inst Technology, The Massachusetts General Hospital
What technology area does this patent fall under?
Primary CPC classification G01N1/405. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).